Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study.

Abdellaoui S, Al Tabaa O, Hilliquin S, d'Alessandro R, Hecquet S, Thomas M, Carvès S, Combier A, Allanore Y, Avouac J

Open source

DOI
10.1007/s10067-026-08175-y
Published
2026 Jul
Container
Clinical rheumatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10067-026-08175-y,
  title = {Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study.},
  author = {Abdellaoui S and Al Tabaa O and Hilliquin S and d'Alessandro R and Hecquet S and Thomas M and Carvès S and Combier A and Allanore Y and Avouac J},
  year = {2026},
  journal = {Clinical rheumatology},
  doi = {10.1007/s10067-026-08175-y},
  url = {https://doi.org/10.1007/s10067-026-08175-y}
}

RIS

TY  - JOUR
TI  - Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study.
AU  - Abdellaoui S
AU  - Al Tabaa O
AU  - Hilliquin S
AU  - d'Alessandro R
AU  - Hecquet S
AU  - Thomas M
AU  - Carvès S
AU  - Combier A
AU  - Allanore Y
AU  - Avouac J
PY  - 2026
JO  - Clinical rheumatology
DO  - 10.1007/s10067-026-08175-y
UR  - https://doi.org/10.1007/s10067-026-08175-y
ER  - 

APA

S, A., O, A. T., S, H., R, D., S, H., M, T., S, C., A, C., Y, A., & J, A. (2026). Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study.. Clinical rheumatology. https://doi.org/10.1007/s10067-026-08175-y

Source records